Literature DB >> 18310132

Functional alpha7-containing nicotinic acetylcholine receptors localize to cell bodies and proximal dendrites in the rat substantia nigra pars reticulata.

Olga V Poisik1, Jian-xin Shen, Susan Jones, Jerrel L Yakel.   

Abstract

The substantia nigra pars reticulata (SNr) is the primary output nucleus for the basal ganglia (BG) in the rat. The SNr is reciprocally connected with the pedunculopontine tegmental nucleus (PPN) in the brainstem, which provides cholinergic innervation to most BG nuclei. The cholinergic input into the BG is considered to be important because PPN activity is altered in Parkinson's disease (PD), a neurological disorder involving the BG, and cholinergic pharmacotherapy is beneficial in alleviating some of its symptoms. In order to better understand the role of cholinergic input to the BG, we examined the effects of nicotinic acetylcholine receptor (nAChR) activation in the GABAergic neurons in slices through juvenile rat SNr. With the aide of subtype selective antagonists, we found that SNr neurons express the alpha7 subtype of nAChRs, the function of which we assessed using the whole cell patch-clamp recording technique. Besides alpha7 nAChRs, GABAergic SNr neurons also contained functional non-alpha7 nAChRs. Using local photolysis of caged carbachol, a broad-spectrum cholinergic agonist, we mapped alpha7 nAChR-mediated currents along the visible extent of filled SNr neurons and found that alpha7 nAChRs can be functionally detected as far as 60 microm away from the soma. Our data are paving the way to a better understanding of the physiological roles of nAChRs in the BG.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18310132      PMCID: PMC2375669          DOI: 10.1113/jphysiol.2008.149963

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  68 in total

Review 1.  Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions.

Authors:  G E Alexander; M D Crutcher; M R DeLong
Journal:  Prog Brain Res       Date:  1990       Impact factor: 2.453

Review 2.  Functional architecture of basal ganglia circuits: neural substrates of parallel processing.

Authors:  G E Alexander; M D Crutcher
Journal:  Trends Neurosci       Date:  1990-07       Impact factor: 13.837

3.  Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro.

Authors:  A A Grace; S P Onn
Journal:  J Neurosci       Date:  1989-10       Impact factor: 6.167

4.  The pedunculopontine nucleus in Parkinson's disease.

Authors:  R M Zweig; W R Jankel; J C Hedreen; R Mayeux; D L Price
Journal:  Ann Neurol       Date:  1989-07       Impact factor: 10.422

Review 5.  Smoking, nicotine and Parkinson's disease.

Authors:  Maryka Quik
Journal:  Trends Neurosci       Date:  2004-09       Impact factor: 13.837

6.  Biochemical and histochemical evidence of nonspecific binding of alpha7nAChR antibodies to mouse brain tissue.

Authors:  Donna L Herber; Emily G Severance; Javier Cuevas; Dave Morgan; Marcia N Gordon
Journal:  J Histochem Cytochem       Date:  2004-10       Impact factor: 2.479

7.  Regulation of nicotinic acetylcholine receptor channel function by acetylcholinesterase inhibitors in rat hippocampal CA1 interneurons.

Authors:  Dmitriy Fayuk; Jerrel L Yakel
Journal:  Mol Pharmacol       Date:  2004-09       Impact factor: 4.436

8.  Pharmacological properties of the homomeric alpha 7 receptor.

Authors:  D Bertrand; S Bertrand; M Ballivet
Journal:  Neurosci Lett       Date:  1992-10-26       Impact factor: 3.046

9.  Autoradiographic localization of putative nicotinic receptors in the rat brain using 125I-neuronal bungarotoxin.

Authors:  D W Schulz; R H Loring; E Aizenman; R E Zigmond
Journal:  J Neurosci       Date:  1991-01       Impact factor: 6.167

10.  Pedunculopontine nucleus and basal ganglia: distant relatives or part of the same family?

Authors:  Juan Mena-Segovia; J Paul Bolam; Peter J Magill
Journal:  Trends Neurosci       Date:  2004-10       Impact factor: 13.837

View more
  5 in total

Review 1.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

Review 2.  Intrinsic and integrative properties of substantia nigra pars reticulata neurons.

Authors:  F-M Zhou; C R Lee
Journal:  Neuroscience       Date:  2011-08-02       Impact factor: 3.590

Review 3.  The therapeutic potential of α7 nicotinic acetylcholine receptor (α7 nAChR) agonists for the treatment of the cognitive deficits associated with schizophrenia.

Authors:  Corinne Beinat; Samuel D Banister; Marco Herrera; Vivian Law; Michael Kassiou
Journal:  CNS Drugs       Date:  2015-07       Impact factor: 5.749

Review 4.  Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions.

Authors:  Kalynda K Gonzales; Yoland Smith
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

5.  Characterization of a nicotine-sensitive neuronal population in rat entorhinal cortex.

Authors:  Bin Tu; Zhenglin Gu; Jian-Xin Shen; Patricia W Lamb; Jerrel L Yakel
Journal:  J Neurosci       Date:  2009-08-19       Impact factor: 6.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.